Marianna Mancini - 15 Jan 2022 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Chief Operating Officer
Signature
/s/Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
15 Jan 2022
Net transactions value
-$3,506
Form type
4
Filing time
11 Feb 2022, 17:34:39 UTC
Previous filing
05 Jan 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Tax liability $3,506 -827 -0.35% $4.24 238,695 15 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.